HUNTINGTON NATIONAL BANK - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11,268
-9.6%
245
+12.9%
0.00%
Q2 2023$12,471
-22.5%
217
-49.4%
0.00%
Q1 2023$16,088
+27.0%
429
-5.1%
0.00%
Q4 2022$12,666
+5.6%
452
+10.0%
0.00%
Q3 2022$12,000
+300.0%
411
+377.9%
0.00%
Q2 2022$3,000860.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders